Approval for the thoratec implantable ventricular assist device (ivad) as an alternate vad blood pump for use in the approved thoratec ventricular assist device system.  The device, as modified, will be marketed under the trade name thoratec implantable ventricular assist device and is indicated for use in bridge to transplant patients who meet all of the following criteria: candidate for cardiac transplantation, imminent risk of dying before donor heart procurement, dependence on, or incomplete response to, continued vasopressor support.  It is also indicated for postcardiotomy recovery patients who are unable to be weaned from cardiopulmonary bypass.  In addition, the ivad is designed to be compatible with both the dual driver console and tlc-ii portable vad driver.